| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.005 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.088 | 0.007 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.08 | 0.01 |